GlassScriptPhysician profile
Therese Vivas
NPI 1477389435
$1,567.71
in general payments reported to CMS, 2019-2025
17 companies · $1,268 in 2025
The $1,268 reported for 2025 was more than what 89% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $300 · 2025: $1,268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,483 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,482.72 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $279.88 | 2025 | |
| Janssen Biotech, INC. | $252.49 | 2024-2025 | Erleada |
| Sumitomo Pharma America, INC. | $174.42 | 2025 | Gemtesa |
| Tolmar, INC. | $146.80 | 2024-2025 | Eligard, Jatenzo |
| Bioprotect Medical, INC. | $144.38 | 2024-2025 | Bioprotect Balloon Implant System |
| Astrazeneca Pharmaceuticals LP | $87.90 | 2024-2025 | Lynparza |
| Immunitybio, INC. | $85.72 | 2025 | |
| Merck Sharp & Dohme LLC | $76.11 | 2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $75.65 | 2025 | |
| Urogen Pharma, INC. | $68.78 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $38.70 | 2025 | |
| Progenics Pharmaceuticals, INC. | $30.18 | 2025 | |
| Civco Medical Instruments | $29.26 | 2025 | |
| Hologic Sales and Service, LLC | $24.31 | 2025 | Aptima |
| Pfizer INC. | $22.45 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $16.04 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Teleflex LLC | $14.64 | 2024 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Therese Vivas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.